These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 209066)

  • 41. The pathogenicity of louping ill virus for mice and lambs.
    Sheahan BJ; Moore M; Atkins GJ
    J Comp Pathol; 2002; 126(2-3):137-46. PubMed ID: 11945002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Louping-ill virus in red grouse in Scotland.
    Reid HW; Boyce JB
    Vet Rec; 1974 Aug; 95(7):150. PubMed ID: 4375344
    [No Abstract]   [Full Text] [Related]  

  • 43. A serological examination of Scottish strains of louping ill and their relation to other members of the complex.
    Thorburn H; Williams H
    Arch Gesamte Virusforsch; 1966; 19(2):155-60. PubMed ID: 4964505
    [No Abstract]   [Full Text] [Related]  

  • 44. Development of a non-infective protective antigen against louping-ill (arbovirus group B). Laboratory experiments.
    Brotherston JG; Boyce JB
    J Comp Pathol; 1970 Jul; 80(3):377-88. PubMed ID: 5529405
    [No Abstract]   [Full Text] [Related]  

  • 45. [Specific and nonspecific induction of resistance to Listeria infection and hypersensitivity to Listeria factor Ei (author's transl)].
    Mára M; Menciková E; John C; Bednár M; Miková Z; Klecáková M
    Cesk Epidemiol Mikrobiol Imunol; 1979 Sep; 28(5):260-7. PubMed ID: 161513
    [No Abstract]   [Full Text] [Related]  

  • 46. CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1.
    Lakhan N; Stevens NE; Diener KR; Hayball JD
    J Immunol Methods; 2016 Dec; 439():37-43. PubMed ID: 27693642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of concurrent scrapie on louping-ill encephalitis in the mouse.
    Doherty PC; Rennie JC; Smith W
    Res Vet Sci; 1972 Mar; 13(2):146-9. PubMed ID: 4556469
    [No Abstract]   [Full Text] [Related]  

  • 48. The assessment in sheep of an inactivated vaccine of parainfluenza 3 virus incorporating double stranded RNA (BRL 5907) as adjuvant.
    Wells PW; Sharp JM; Burrells C; Rushton B; Smith WD
    J Hyg (Lond); 1976 Oct; 77(2):255-61. PubMed ID: 185290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization of chickens with an inactivated oil-adjuvant Newcastle disease virus vaccine.
    Levy R; Zakay-Rones Z
    Avian Dis; 1973; 17(3):598-604. PubMed ID: 4355964
    [No Abstract]   [Full Text] [Related]  

  • 50. Modification of the response to Freund's adjuvant by chloramphenicol.
    Moore RD
    J Reticuloendothel Soc; 1973 Jul; 14(1):26-43. PubMed ID: 4582975
    [No Abstract]   [Full Text] [Related]  

  • 51. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Freund's complete and incomplete adjuvants, preparation, and quality control standards for experimental laboratory animals use.
    Stewart-Tull DE
    Methods Mol Biol; 2010; 626():59-72. PubMed ID: 20099121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model.
    Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM
    Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, spatial distribution and the effect of control measures on louping-ill virus in the Forest of Bowland, Lancashire.
    Laurenson MK; McKendrick IJ; Reid HW; Challenor R; Mathewson GK
    Epidemiol Infect; 2007 Aug; 135(6):963-73. PubMed ID: 17346361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic variation among members of the tick-borne encephalitis complex.
    Stephenson JR; Lee JM; Wilton-Smith PD
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():81-9. PubMed ID: 6198450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the development of a vaccine against bovine ephemeral fever.
    Theodoridis A; Boshoff SE; Botha MJ
    Onderstepoort J Vet Res; 1973 Sep; 40(3):77-82. PubMed ID: 4788558
    [No Abstract]   [Full Text] [Related]  

  • 58. Assay of neutralizing antibodies against louping ill virus by metabolic inhibition test.
    Kääriäinen L
    Ann Med Exp Biol Fenn; 1965; 43(3):137-42. PubMed ID: 5865858
    [No Abstract]   [Full Text] [Related]  

  • 59. Tick-Borne Encephalitis in Sheep, Romania.
    Salat J; Mihalca AD; Mihaiu M; Modrý D; Ruzek D
    Emerg Infect Dis; 2017 Dec; 23(12):2065-2067. PubMed ID: 29148377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulation of mosquito-borne viruses in large-scale sheep farms in eastern Slovakia.
    Juricová Z; Mitterpák J; Prokopic J; Hubálek Z
    Folia Parasitol (Praha); 1986; 33(3):285-8. PubMed ID: 3758873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.